CAPSTONE INVESTMENT ADVISORS, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$25,000
-88.0%
14,719
-88.8%
0.00%
-100.0%
Q4 2020$209,000131,3630.00%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 2,595,484$10,564,0009.31%
Cypress Capital Management LLC (WY) 108,400$441,0000.50%
Noven Financial Group, Inc. 158,059$643,0000.37%
Transform Wealth, LLC 205,481$836,0000.15%
GHP Investment Advisors, Inc. 100,000$407,0000.06%
Pratt Collard Advisory Partners LLC 15,600$63,0000.05%
JANICZEK WEALTH MANAGEMENT, LLC 16,719$68,0000.04%
Virtu Financial LLC 92,344$376,0000.02%
JFS WEALTH ADVISORS, LLC 18,150$74,0000.02%
CONDOR CAPITAL MANAGEMENT 21,400$87,0000.02%
View complete list of AMPIO PHARMACEUTICALS INC shareholders